Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea-Reference-Cited by-同舟云学术

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

Published:2019-04-16 Issue:15 Volume:321 Page:1466
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Rosenstock Julio¹,Allison Dale²,Birkenfeld Andreas L.³⁴,Blicher Thalia Marie⁵,Deenadayalan Srikanth⁵,Jacobsen Jacob Bonde⁵,Serusclat Pierre⁶,Violante Rafael⁷,Watada Hirotaka⁸,Davies Melanie⁹,

Affiliation:

1. Dallas Diabetes Research Center at Medical City, Dallas, Texas

2. Hillcrest Family Health Center, Waco, Texas

3. Department of Medicine III, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany

4. Paul Langerhans Institute Dresden, Helmholtz Center Munich at Technische Universität Dresden, Dresden, Germany

5. Novo Nordisk A/S, Søborg, Denmark

6. Endocrinology, Diabetology and Nutrition, Clinique Portes du Sud, Venissieux, France

7. Departamento Endocrinología, Instituto Mexicano del Seguro Social, Ciudad Madero, Mexico

8. Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan

9. Diabetes Research Centre, University of Leicester, Leicester, England

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/15/1466/17489573/jama_rosenstock_2019_oi_190026.pdf

Reference32 articles.

1. Management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).;Davies;Diabetes Care,2018

2. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.;Stark Casagrande;Diabetes Care,2013

3. Standards of Medical Care in Diabetes—2018, 8: pharmacologic approaches to glycemic treatment.;American Diabetes Association;Diabetes Care,2018

4. Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: a meta-analysis of randomized clinical trials.;Tran;Diabetes Obes Metab,2018

5. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.;Scirica;N Engl J Med,2013

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin therapy in feline diabetes mellitus – A review of the current state of research;Domestic Animal Endocrinology;2024-10

2. Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study;2024-09-09

3. Antidiabetic potential of sea fish mass by inhibiting di-peptidyl peptidase-IV and augmenting glucagon-like peptide-1 on high lipid diet and streptozotocin induced diabetic rats;Pharmacological Research - Natural Products;2024-09

4. Antidiabetic and Anti-Inflammatory Effect of Cinnamomum cassia Oil in Alloxan-Induced Diabetic Rats;Pharmaceuticals;2024-08-29

5. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17